Beneficial metabolic effects of exogenous FGF21 administration were also observed in obese or diabetic primates [73,74] and in humans [74,75], although the improvements in hyperglycaemia were disappointingly modest in humans. This evidence concerns the gene FGF21 and Hyperglycemia.